Amnioinfusion vs. standard management for the second trimester PPROM: a systematic review and meta-analysis of observational studies and RCTs

References

• Everest NJ, Jacobs SE, Davis PG, et al. Outcomes following prolonged preterm premature rupture of the membranes. Arch Dis Child Fetal Neonatal Ed. 2008;93:F207–F211.
   PubMed Web of Science ®Google Scholar
• Linehan LA, Walsh J, Morris A, et al. Neonatal and maternal outcomes following midtrimester preterm premature rupture of the membranes: a retrospective cohort study. BMC Pregnancy Childbirth. 2016;16(1):25. doi: 10.1186/s12884-016-0813-3.
   PubMedGoogle Scholar
• Muris C, Girard B, Creveuil C, et al. Management of premature rupture of membranes before 25 weeks. Eur J Obstet Gynecol Reprod Biol. 2007;131(2):163–168. doi: 10.1016/j.ejogrb.2006.05.016.
   PubMed Web of Science ®Google Scholar
• Taylor J, Garite TJ. Premature rupture of membranes before fetal viability. Obstet Gynecol. 1984;64:615–620.
   PubMed Web of Science ®Google Scholar
• Crowley AE, Grivell RM, Dodd JM. Sealing procedures for preterm prelabour rupture of membranes. Cochrane Database Syst Rev. 2016;7(7):CD010218. doi: 10.1002/14651858.CD010218.pub2.
   PubMedGoogle Scholar
• Miyazaki K, Furuhashi M, Yoshida K, et al. Aggressive intervention of previable preterm premature rupture of membranes. Acta Obstet Gynecol Scand. 2012;91:923–929.
   PubMed Web of Science ®Google Scholar
• Ogunyemi D, Thompson W. A case controlled study of serial transabdominal amnioinfusions in the management of second trimester oligohydramnios due to premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol. 2002;102(2):167–172. doi: 10.1016/S0301-2115(01)00612-1.
   PubMed Web of Science ®Google Scholar
• Stringer M, Librizzi R, Weiner S. Management of midtrimester oligohydramnios: a case for amnioinfusion. J Perinatol. 1990;10:143–145.
   PubMedGoogle Scholar
• Vergani P, Locatelli A, Strobelt N, et al. Amnioinfusion for prevention of pulmonary hypoplasia in second-trimester rupture of membranes. Am J Perinatol. 1997;14:325–329.
   PubMed Web of Science ®Google Scholar
• Locatelli A, Andreani M, Ghidini A, et al. Amnioinfusion in preterm PROM: effects on amnion and cord histology. J Perinatol. 2008;28(2):97–101. doi: 10.1038/sj.jp.7211876.
   PubMed Web of Science ®Google Scholar
• Porat S, Amsalem H, Shah PS, et al. Transabdominal amnioinfusion for preterm premature rupture of membranes: a systematic review and metaanalysis of randomized and observational studies. Am J Obstet Gynecol. 2012;207(5):393.e1–393.e11. doi: 10.1016/j.ajog.2012.08.003.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Ono T, Tsumura K, Kawasaki I, et al. Continuous amnioinfusion for treatment of mid-trimester preterm premature rupture of membranes with oligoamnios. J Obstet Gynaecol Res. 2020;46(1):79–86. doi: 10.1111/jog.14151.
   PubMed Web of Science ®Google Scholar
• Esaki M, Maseki Y, Tezuka A, et al. Continuous amnioinfusion in women with PPROM at periviable gestational ages. J Matern Fetal Neonatal Med. 2020;33:1151–1156.
   PubMed Web of Science ®Google Scholar
• Goździewicz T, Rycel-Dziatosz M, Madziar K, et al. Long-term amnioinfusion through an intrauterine catheter in preterm premature rupture of membranes before 26 weeks of gestation: a retrospective multicenter study. Fetal Diagn Ther. 2021;48(8):582–587. doi: 10.1159/000517754.
   PubMed Web of Science ®Google Scholar
• Roberts D, Vause S, Martin W, et al. Amnioinfusion in preterm premature rupture of membranes (AMIPROM): a randomised controlled trial of amnioinfusion versus expectant management in very early preterm premature rupture of membranes – a pilot study. Health Technol Assess. 2014;18:1–135.
   Web of Science ®Google Scholar
• Van Kempen LEM, Van Teeffelen AS, De Ruigh AA, et al. Amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a randomized controlled trial. Obstet Gynecol. 2019;133(1):129–136. doi: 10.1097/AOG.0000000000003003.
   PubMed Web of Science ®Google Scholar
• de Ruigh AA, Simons NE, van ’t Hooft J, et al. Child outcomes after amnioinfusion compared with no intervention in women with second-trimester rupture of membranes: a long-term follow-up study of the PROMEXIL-III trial. BJOG. 2021;128:292–301.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi: 10.1136/bmj.l4898.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Cochrane Methods. Assessing risk of bias in included studies. Cochrane bias. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editors. Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0; 2018.
   Google Scholar
• Garzetti GG, Ciavattini A, De Cristofaro F, et al. Prophylactic transabdominal amnioinfusion in oligohydramnios for preterm premature rupture of membranes: increase of amniotic fluid index during latency period? Gynecol Obstet Invest. 1997;44(4):249–254. doi: 10.1159/000291538.
   PubMed Web of Science ®Google Scholar
• Gramellini D, Fieni S, Kaihura C, et al. Transabdominal antepartum amnioinfusion. Int J Gynecol Obstet. 2003;83(2):171–178. doi: 10.1016/S0020-7292(03)00274-1.
   PubMed Web of Science ®Google Scholar
• Fisk NM, Ronderos-Dumit D, Soliani A, et al. Diagnostic and therapeutic transabdominal amnioinfusion in oligohydramnios. Obstet Gynecol. 1991;78:270–278.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Giannubilo SR, Bezzeccheri V, et al. Transabdominal amnioinfusion in preterm premature rupture of membranes: a randomised controlled trial. BJOG. 2005;112:759–763.
   PubMed Web of Science ®Google Scholar
• Singla A, Yadav P, Vaid NB, et al. Transabdominal amnioinfusion in preterm premature rupture of membranes. Int J Gynecol Obstet. 2010;108(3):199–202. doi: 10.1016/j.ijgo.2009.09.032.
   PubMed Web of Science ®Google Scholar
• Fatima S, Tasnim N, Mahmud G. The effect of transabdominal amnioinfusion on perinatal outcomes in preterm premature rupture of membranes. Journal of SAFOG. 2014;6:28–32.
   Google Scholar
• Tsuda A. Transabdominal amnioinfusion therapy with antibiotics for preterm premature rupture of membranes before 26 weeks of gestation. Journal of Maternal-Fetal Investigation. 1996;6:171–174.
   Google Scholar
• Szabó I, Szilágyi A, Gács E, et al. Amnioinfusion for management of preterm prelabour rupture of membranes. Lancet. 1993;341(8842):443–444. doi: 10.1016/0140-6736(93)93046-4.
   PubMed Web of Science ®Google Scholar
• Hsu TL, Hsu TY, Tsai CC, et al. The experience of amnioinfusion for oligohydramnios during the early second trimester. Taiwan J Obstet Gynecol. 2007;46:395–398.
   PubMedGoogle Scholar
• Locatelli A, Vergani P, Di Pirro G, et al. Role of amnioinfusion in the management of premature rupture of the membranes at <26 weeks’ gestation. Am J Obstet Gynecol. 2000;183:878–882.
   PubMed Web of Science ®Google Scholar
• Melekoglu R, Celik E. Perinatal and neonatal outcomes of women with very early preterm premature rupture of membranes treated via serial transabdominal amnioinfusion and expectant management: experience of a tertiary referral center in Turkey. J Obstet Gynaecol Res. 2022;48(7):1732–1739. doi: 10.1111/jog.15290.
   PubMed Web of Science ®Google Scholar
• De Santis M, Scavo M, Noia G, et al. Transabdominal amnioinfusion treatment of severe oligohydramnios in preterm premature rupture of membranes at less than 26 gestational weeks. Fetal Diagn Ther. 2003;18(6):412–417. doi: 10.1159/000073134.
   PubMed Web of Science ®Google Scholar
• De Carolis MP, Romagnoli C, De Santis M, et al. Is there significant improvement in neonatal outcome after treating pPROM mothers with amnio-infusion? Biol Neonate. 2004;86:222–229.
   PubMedGoogle Scholar
• Nourse CB, Steer PA. Perinatal outcome following conservative management of mid-trimester pre-labour rupture of the membranes. J Paediatr Child Health. 1997;33(2):125–130. doi: 10.1111/j.1440-1754.1997.tb01014.x.
   PubMed Web of Science ®Google Scholar
• Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol. 1996;174(4):1371–1376. doi: 10.1016/S0002-9378(96)70687-7.
   PubMed Web of Science ®Google Scholar
• Pappas A, Kendrick DE, Shankaran S, et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 2014;168(2):137. doi: 10.1001/jamapediatrics.2013.4248.
   PubMed Web of Science ®Google Scholar
• Maisonneuve E, Ancel PY, Foix-L’Hélias L, et al. Impact of clinical and/or histological chorioamnionitis on neurodevelopmental outcomes in preterm infants: a literature review. J Gynecol Obstet Hum Reprod. 2017;46(4):307–316.
   PubMed Web of Science ®Google Scholar
• Hatfield T, Wing DA, Buss C, et al. Magnetic resonance imaging demonstrates long-term changes in brain structure in children born preterm and exposed to chorioamnionitis. Am J Obstet Gynecol. 2011;205(4):384.e1–384.e8. doi: 10.1016/j.ajog.2011.07.027.
   PubMed Web of Science ®Google Scholar
• Costeloe KL, Hennessy EM, Haider S, et al. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ. 2012;345(3):e7976. doi: 10.1136/bmj.e7976.
   PubMed Web of Science ®Google Scholar